Skip to main content
. 2020 Jul 7;20(3):2962–2968. doi: 10.3892/ol.2020.11821

Figure 1.

Figure 1.

High expression levels of ZNF281 in NSCLC predict poor survival. (A) ZNF281 expression was measured by reverse transcription-quantitative PCR and compared between non-tumor and NSCLC tissues using a paired Student's t-test. (B) A total of 66 patients with NSCLC were divided into high-(n=33) and low-ZNF281 (n=33) expression level groups according to its median expression level in NSCLC. GraphPad Prism 6 software was used to plot survival curves and the log-rank test was used to compare these. *P<0.05. ZNF281, zinc finger protein 281; NSCLC, non-small cell lung cancer.